Kenneth M. Bate has served as Chairman since December 2021. Mr. Bate is currently an independent biotech industry consultant. He previously served as President and Chief Executive Officer of Archemix, Inc. from May 2009 to January 2012. From 2006 to 2009, Mr. Bate served in various positions at Nitromed, Inc., most recently as President and Chief Executive Officer. From 2002 to 2005, Mr. Bate served as Chief Financial Officer and head of commercial operations of Millennium Pharmaceuticals Inc. Mr. Bate served as the Chairman of the Board of Cubist Pharmaceuticals, Inc. from 2011 to 2015. In addition to serving on the Board of Directors of AVEO, Mr. Bate serves on the Board of Genocea Biosciences, Inc., Catabasis Pharmaceuticals, Inc. Epizyme, Inc. and TransMedics, Inc. Mr. Bate received his B.A. in Chemistry from Williams College and his M.B.A. from the Wharton School of the University of Pennsylvania. Mr. Bate has served as a director of AVEO since 2007 and is the current chairperson of the audit committee and is a member of nominating and governance committee.